TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs

For patients with advanced or metastatic Hepatocellular carcinoma (HCC) who are not suitable for surgical resection, systemic therapy has been considered to be the standard treatment. In recent years, a small subset of patients with unresectable HCC have been benefit from tyrosine kinase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chong, Jin, Xin, Liu, Xingchao, Wu, Gang, Yang, Wenhao, Pang, Beichuan, Jiang, Jipeng, Liao, Dongxu, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859813/
https://www.ncbi.nlm.nih.gov/pubmed/36670097
http://dx.doi.org/10.1038/s41419-023-05577-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859813/
https://www.ncbi.nlm.nih.gov/pubmed/36670097
http://dx.doi.org/10.1038/s41419-023-05577-7

Ejemplares similares